AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

LBA43 Spartalizumab plus dabrafenib and trametinib (Sparta-DabTram) in patients (pts) with previously untreated BRAF V600–mutant unresectable or metastatic melanoma: Results from the randomized part 3 of the phase III COMBI-i trial

P. Nathan, R. Dummer,G.V. Long,P.A. Ascierto,H.A. Tawbi, C. Robert, P. Rutkowski, O. Leonov, C. Dutriaux, M. Mandala',P. Lorigan,P.F. Ferrucci,K.T. Flaherty, J.C. Brase,S. Green,T. Haas, A. Masood,E. Gasal,A. Ribas,D. Schadendorf

ANNALS OF ONCOLOGY（2020）

引用 61|浏览25
暂无评分
关键词
metastatic melanoma,untreated dabrafenib v600–mutant,sparta-dabtram
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要